The stock price of ClearPoint Neuro Inc (NASDAQ: CLPT) has dropped by -6.93 compared to previous close of 13.42. Despite this, the company has seen a fall of -3.10% in its stock price over the last five trading days. seekingalpha.com reported 2024-11-07 that ClearPoint Neuro, Inc. (NASDAQ:CLPT ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Joe Burnett – President & Chief Executive Officer Danilo D’Alessandro – Chief Financial Officer Conference Call Participants Frank Takkinen – Lake Street Capital Operator Greetings, and welcome to the ClearPoint Neuro, Inc. Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in listen-only mode.
Is It Worth Investing in ClearPoint Neuro Inc (NASDAQ: CLPT) Right Now?
The stock has a 36-month beta value of 1.11. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CLPT is 23.97M, and at present, short sellers hold a 2.97% of that float. On November 08, 2024, the average trading volume of CLPT was 210.24K shares.
CLPT’s Market Performance
CLPT stock saw an increase of -3.10% in the past week, with a monthly gain of 9.66% and a quarterly increase of 27.71%. The volatility ratio for the week is 4.97%, and the volatility levels for the last 30 days are 6.47% for ClearPoint Neuro Inc (CLPT). The simple moving average for the last 20 days is -2.05% for CLPT’s stock, with a simple moving average of 52.25% for the last 200 days.
Analysts’ Opinion of CLPT
Many brokerage firms have already submitted their reports for CLPT stocks, with B. Riley Securities repeating the rating for CLPT by listing it as a “Buy.” The predicted price for CLPT in the upcoming period, according to B. Riley Securities is $10 based on the research report published on July 25, 2024 of the current year 2024.
Stifel, on the other hand, stated in their research note that they expect to see CLPT reach a price target of $8. The rating they have provided for CLPT stocks is “Buy” according to the report published on October 24th, 2023.
B. Riley Securities gave a rating of “Buy” to CLPT, setting the target price at $14 in the report published on February 16th of the previous year.
CLPT Trading at 2.71% from the 50-Day Moving Average
After a stumble in the market that brought CLPT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.58% of loss for the given period.
Volatility was left at 6.47%, however, over the last 30 days, the volatility rate increased by 4.97%, as shares surge +4.65% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -7.81% lower at present.
During the last 5 trading sessions, CLPT fell by -5.74%, which changed the moving average for the period of 200-days by +71.61% in comparison to the 20-day moving average, which settled at $12.73. In addition, ClearPoint Neuro Inc saw 83.95% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for CLPT
Current profitability levels for the company are sitting at:
- -0.66 for the present operating margin
- 0.6 for the gross margin
The net margin for ClearPoint Neuro Inc stands at -0.64. The total capital return value is set at -0.52. Equity return is now at value -60.40, with -35.89 for asset returns.
Based on ClearPoint Neuro Inc (CLPT), the company’s capital structure generated 0.3 points at debt to capital in total, while cash flow to debt ratio is standing at -0.69. The debt to equity ratio resting at 0.43. The interest coverage ratio of the stock is -97.24.
Currently, EBITDA for the company is -20.99 million with net debt to EBITDA at 1.11. When we switch over and look at the enterprise to sales, we see a ratio of 11.2. The receivables turnover for the company is 6.2for trailing twelve months and the total asset turnover is 0.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.79.
Conclusion
To sum up, ClearPoint Neuro Inc (CLPT) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
